2022 the Japanese Society of Medical Oncology Annual Meeting

Presentation information

Oral Session

[O14] Oral Session 14 Gynecologic Cancer
【E】

Sat. Feb 19, 2022 3:00 PM - 4:10 PM Room 5 (Room B-1, 2F, Kyoto International Conference Center)

Chair:Noriyuki Katsumata(Department of Medical Oncology, Nippon Medical School Musashikosugi Hospital ),Keiichi Fujiwara(Department of Gynecologic Oncology, Saitama Medical University International Medical Center)
Discussant:Mayu Yunokawa(Department of Gynecology Oncology and Department of Medical Oncology, Cancer Institute hospital of JFCR)

[O14-1] Pembrolizumab + Chemotherapy in Japanese Patients With Persistent, Recurrent, or Metastatic Cervical Cancer: KEYNOTE-826

Kan Yonemori1, Shin Nishio2, Tomoka Usami3, Shinichiro Minobe4, Mayu Yunokawa5, Takashi Iwata6, Aikou Okamoto7, Yoichi Aoki8, Hiroaki Itamochi9, Munetaka Takekuma10, Kenichi Harano11, Keiko Yamamoto12, Hiroyuki Ugai12, Cumhur Tekin13, Sarper Toker13, Nicoletta Colombo14, Keiichi Fujiwara15, Kosei Hasegawa15 (1.Department of Medical Oncology, National Cancer Center Hospital, 2.Kurume University Hospital, Fukuoka, Japan, 3.Ehime University Hospital, Ehime, Japan, 4.Hokkaido Cancer Center, Hokkaido, Japan, 5.Cancer Institute Hospital of JFCR, Tokyo, Japan, 6.Keio University Hospital, Tokyo, Japan, 7.The Jikei University Hospital, Tokyo, Japan, 8.University of the Ryukyus Hospital, Okinawa, Japan, 9.Iwate Medical University Hospital, Iwate, Japan, 10.Shizuoka Cancer Center, Shizuoka, Japan, 11.National Cancer Center Hospital East, Kashiwa, Japan, 12.MSD K.K., Tokyo, Japan, 13.Merck & Co., Inc., Kenilworth, NJ, USA, 14.European Institute of Oncology IRCCS and Università degli Studi di Milano Bicocca, Milan, Italy, 15.Saitama Medical University International Medical Center, Saitama, Japan)

Abstract password authentication.
The password can be found on page 27 of the program book.

Password